Furthermore, pharmacological inhibition of FASN has been shown to be lethal to cancer cells in vitro and in vivo but not to normal cells[105], highlighting the importance of FAs in cancer biology while simultaneously revealing a promising therapeutic window. The gene discussed is FASN; the disease is cancer.